gene

CTSD

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CTSD: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1555Connections
1Hypotheses
6Analyses
50Outgoing
50Incoming
0Experiments
15Debates

Summary

CTSD is a gene implicated in neurodegeneration research. Key relationships include: interacts with, associated with, regulates. Associated with AD, ADH, ALI. Connected to 651 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolCTSD
Full NameCathepsin D
AliasesCPSD, CLN10
Chromosome11p15.5
Protein TypeProtease
Functionis a lysosomal aspartic protease encoded by the CTSD gene.
Primary ExpressionBrain, liver, macrophages, neurons, microglia
Molecular Weight48 kDa
PathwaysAkt, Angiogenesis, Apoptosis, Autophagy, Blood-Brain Barrier
UniProt IDP07339
NCBI Gene ID1509
Ensembl IDENSG00000103811
GeneCardsCTSD
Human Protein AtlasCTSD
Pre-proenzymeSignal peptide + prosegment + mature enzyme
Associated DiseasesAD, ADH, Aging, ALI, Als
Known Drugs/CompoundsCHLOROQUINE, COENZYME Q10, H2S, rapamycin, RAPAMYCIN
InteractionsABCA1, ABCD3, ACTB, Actin, ADRA2A, AGING
SciDEX HypothesesCathepsin D Enhancement for Tau Degradation
KG Connections1554 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: CTSD — AlphaFold P07339 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (7)

Knowledge base pages for this entity

Canonical Page

CTSD — Cathepsin D

gene · 776 words

CTSD Gene - Cathepsin D

gene · 2704 words

CTSD — Cathepsin D

gene · 2576 words

CTSD (Cathepsin D)

protein · 2079 words

Cathepsin D (CTSD)

protein · 1652 words

CTSD Protein - Cathepsin D

protein · 644 words

Pathway Diagram

graph TD
    CTSD["CTSD"] -->|"activates"| Metabolic_Syndrome["Metabolic Syndrome"]
    CTSD["CTSD"] -->|"regulates"| Ischemia["Ischemia"]
    CTSD["CTSD"] -->|"regulates"| Ms["Ms"]
    CTSD["CTSD"] -->|"interacts"| Dementia["Dementia"]
    CTSD["CTSD"] -->|"interacts"| Cardiovascular["Cardiovascular"]
    CTSD["CTSD"] -->|"interacts"| Als["Als"]
    ACTB["ACTB"] -->|"regulates"| CTSD["CTSD"]
    PPARA["PPARA"] -->|"regulates"| CTSD["CTSD"]
    CAT["CAT"] -->|"regulates"| CTSD["CTSD"]
    SQSTM1["SQSTM1"] -->|"regulates"| CTSD["CTSD"]
    style CTSD fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (989)

TargetRelationTypeStr
CTSDencodesprotein0.00
Amyloid fibril fragmentationmediatesprocess0.95
HSP90αinhibitsprotein0.90
CLN10associated_withdisease0.90
Neuronal ceroid lipofuscinosiscausesdisease0.90

Incoming (566)

SourceRelationTypeStr
CTSDencodesgene0.00
lnc-HIBADH-4regulatesbiomarker0.85
LRP6interacts_withprotein0.80
SLAMF7inhibitsgene0.80
ATGactivatesgene0.80

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Cathepsin D Enhancement for Tau Degradation 0.000 - Tau propagation mechanisms and therapeut

Mentioning Analyses (6)

Scientific analyses that reference this entity

Why have anti-Aβ clinical trials failed despite the established role of Aβ in AD

neurodegeneration | 2026-04-16 | 2 hypotheses Top: 0.741

Neuroinflammation and microglial priming in early AD

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.710

Tau propagation mechanisms and therapeutic interception points

neurodegeneration | 2026-04-04 | 18 hypotheses Top: 0.814

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

neurodegeneration | 2026-04-03 | 19 hypotheses Top: 0.891

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas

neurodegeneration | 2026-04-02 | 7 hypotheses Top: 0.761

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (15)

Multi-agent debates referencing this entity

Second debate: Microglial TREM2-SYK Pathway Enhancement

closed · Rounds: 4 · Score: 0.57 · 2026-04-28

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Primin

closed · Rounds: 4 · Score: 0.12 · 2026-04-27

Debate: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE P

closed · Rounds: 4 · Score: 0.42 · 2026-04-27

Debate: LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability i

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Debate: ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes

closed · Rounds: 4 · Score: 0.47 · 2026-04-27

Should '40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Sele

closed · Rounds: 4 · Score: 0.52 · 2026-04-27

Should 'ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matt

closed · Rounds: 4 · Score: 0.72 · 2026-04-27

The abstract suggests that Aβ-tau synergy could explain negative results from an

closed · Rounds: 4 · Score: 0.65 · 2026-04-16

Investigate prion-like spreading of tau pathology through connected brain region

closed · Rounds: 4 · Score: 0.90 · 2026-04-12

How does microglial priming contribute to early Alzheimer's disease pathology? F

closed · Rounds: 4 · Score: 0.80 · 2026-04-12

Related Research

Hypotheses and analyses mentioning CTSD in their description or question text

No additional research found